Opioid antagonists to prevent olanzapine-induced weight gain: A systematic review
Introduction: Olanzapine (OLZ) is a second generation antipsychotic that is approved for the treatment of schizophrenia, bipolar disorder type 1 as monotherapy (acute manic or mixed episodes, maintenance), or as an add-on to lithium or valproate (manic or mixed episodes). It is one of the most effec...
| Autors principals: | , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
American Association of Psychiatric Pharmacists
2023-08-01
|
| Col·lecció: | Mental Health Clinician |
| Matèries: | |
| Accés en línia: | https://theijpt.org/doi/pdf/10.9740/mhc.2022.08.254 |